Current approaches to neoadjuvant drug therapy for primary operable HER2-positive breast cancer

M. S. Ruban; L. V. Bolotina; Yu. B. Karagodina

Medical alphabet
Medicinskij alfavit

ISSN 2078-5631 (Print)
ISSN 2949-2807 (Online)

User

eng | рус

Medical alphabet

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Ruban M.S., Bolotina L.V., Karagodina Yu.B. Current approaches to neoadjuvant drug therapy for primary operable HER2-positive breast cancer. Medical alphabet. 2024;(32):40-45. (In Russ.) https://doi.org/10.33667/2078-5631-2024-32-40-45

Views PDF (Rus): 1

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2078-5631 (Print)
ISSN 2949-2807 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Petrikov Sergey S.

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

M. S. Ruban
Moscow Research Institute n.a. P.A. Herzen – a Branch of the National Medical Research Centre of Radiology
Russian Federation

Ruban Maxim S., physician-postgraduate student at Dept of Chemotherapy, Systemic Treatment of Solid Tumors Dept

Author ID: 1170985

Moscow

L. V. Bolotina
Moscow Research Institute n.a. P.A. Herzen – a Branch of the National Medical Research Centre of Radiology
Russian Federation

Bolotina Larisa V., DM Sci (habil.), head of Dept of Chemotherapy, Systemic Treatment of Solid Tumors Department

AuthorID: 594953

Moscow

Yu. B. Karagodina
Moscow Research Institute n.a. P.A. Herzen – a Branch of the National Medical Research Centre of Radiology
Russian Federation

Karagodina Yulia B., researcher of Systemic Treatment of Solid Tumors Dept

AuthorID: 1170902

Moscow

Notifications

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Medical alphabet

For citations:

Cookies policy